Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bronchipret in Mild COVID-19
NCT05276375Phase 2Completed
- Sponsor
- Dr. Frank Behrens
- Start
- Jan 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Bronchipret in coronavirus disease 2019 (COVID-19), sponsored by Dr. Frank Behrens. Started Jan 2022; status: completed.
02
Drugs
Bronchipret
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05276375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276375.